Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Adenocarcinoma × Zoledronic Acid × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Pain 2 Neoplasm Metastasis 2 Stomach Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Plasma Cell 1 Myoepithelioma 1 Multiple Myeloma 1 Kidney Neoplasms 1 Humoral Hypercalcemia Of Malignancy 1 Giant Cell Tumors of Bone 1 Desmoplastic Small Round Cell Tumor 1 Chordoma 1 Carcinoma, Renal Cell 1 Ascites 1 Adenocarcinoma 1

Interventions

Gemcitabine 8 pembrolizumab 5 Paclitaxel 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 Nivolumab 3 Fluorouracil 3 Cyclophosphamide 3 Carboplatin 3 sargramostim 2 poly ICLC 2 fludarabine 2 Prednisone 2 Oxaliplatin 2 Irinotecan 2 Hydroxychloroquine 2 Erlotinib Hydrochloride 2 Dexamethasone 2 Cisplatin 2 130-nm albumin-bound paclitaxel 2 temsirolimus 1 tegafur-gimeracil-oteracil 1 spartalizumab 1 sintilimab 1 rucaparib 1 resiquimod 1 repotrectinib 1 regorafenib 1 pralsetinib 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759064 2025-11-19

IPIZA

Qilu Hospital of Shandong University

Phase 1/2 Recruiting

Gastrointestinal

Adenocarcinoma, Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡